We’re thrilled to announce that version 1.11.0 of CluePoints’ Central Monitoring platform, the enabling SaaS platform for Risk-Based Monitoring, will be available to users in April! Version 1.11.0 adds an abundance of new features (as requested by customers) and extensions to existing functionality.
Are you ready for an FDA site inspection?
You may have heard that CluePoints signed an agreement with the FDA. This Cooperative Research and Development Agreement(CRADA) explores a data-driven approach to selecting sites which exhibit data anomalies indicative of fraud, misconduct or sloppiness.
31 October 2016
Cambridge, MA – CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Centralized Statistical Monitoring (CSM) solutions for clinical trials, today announced a new Data Quality Oversight service, RADARTM, aimed at helping sponsors achieve a data-driven understanding of risks to an inspection-ready level.…
We’re delighted to announce that are our next Risk-Based Monitoring implementation webinar is open for registration! Register now – this is THE Risk-Based Monitoring webinar that you need to attend.
With regulatory bodies such as the FDA, EMA, and the ICH all strongly influencing sponsors to adopt a risk-based and centralized approach to site and data monitoring, sponsors are often left wondering how to implement this new paradigm most effectively.